AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.105

+0.0055.00%

Volume:1.07M

Turnover:106.35K

Market Cap:99.16M

PE:-12.32

High:0.105

Open:0.100

Low:0.097

Close:0.100

52wk High:0.330

52wk Low:0.076

Shares:944.39M

Float Shares:375.60M

Volume Ratio:0.87

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.009

EPS(LYR):-0.009

ROE:-34.13%

ROA:-28.69%

PB:3.11

PE(LYR):-12.32

Loading ...

Overview Company News Filings

Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care

MT Newswires Live

Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%

MT Newswires Live

Lumos Diagnostics Secures Three-Year Contract to Manufacture Mold Analyzer; Shares Up 3%

MT Newswires Live

Lumos Diagnostics - First Purchase Order of a$250,000 Under Three-Year Contract

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd - Secures Contract to Manufacture Micro-Pak Mold Analyzer System

THOMSON REUTERS

Lumos Diagnostics Holdings Receives Largest Ever Purchase Order of $1.3 Million, Shares Up 9%

MT Newswires Live

BRIEF-Lumos Diagnostics Receives Largest Febridx Order To Date

Lumos Diagnostics Holdings Ltd - Lumos Receives Largest Febridx Order to Date

THOMSON REUTERS

Lumos Diagnostics - Phase Lodges Purchase Order Valued at US$1.3 Mln for Febridx

THOMSON REUTERS

Lumos Diagnostics to Raise AU$20 Million via Share Placement

MT Newswires Live

BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 Million

BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx

Lumos Diagnostics Holdings - Announces Share Purchase Plan to Raise About a$2.0 Mln

THOMSON REUTERS

Lumos Diagnostics - Offer Price at a$0.225 per Share

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd - US FDA Grants Clia Waiver for Febridx

THOMSON REUTERS

BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response

Lumos Diagnostics Holdings - Seeks Trading Halt Pending Update on FDA Response to Febridx Clia Waiver Application

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LDX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.105,"timestamp":1788156720000,"preClose":0.1,"halted":0,"volume":1070353,"delay":0,"changeRate":0.049999999999999906,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":944389135,"eps":-0.008521004975708152,"marketStatus":"Closed","change":0.005,"latestTime":"08-31 16:12:00 AEST","open":0.1,"high":0.105,"low":0.097,"amount":106352,"amplitude":0.08,"askPrice":0.105,"askSize":179214,"bidPrice":0.097,"bidSize":21825,"shortable":3,"etf":0,"ttmEps":-0.008521004975708152,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.1,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":0.869669,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.1,"auctionPrice":0.105,"auctionVolume":9523,"auctionTime":1788156578573,"referencePrice":0.105,"referenceTime":1788172203092,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156578573}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-28.69%","roe":"-34.13%","lyrEps":-0.008521,"volumeRatio":0.869669,"shares":944389135,"dividePrice":0,"high":0.105,"amplitude":0.08,"preClose":0.1,"low":0.097,"week52Low":0.076,"pbRate":"3.11","psRate":"5.38","week52High":0.33,"institutionHeld":0,"latestPrice":0.105,"committee":-0.782878,"eps":-0.008521004975708152,"divideRate":0,"volume":1070353,"delay":0,"ttmEps":-0.008521004975708152,"open":0.1,"prevYearClose":0.285,"prevWeekClose":0.1,"prevMonthClose":0.1,"prevQuarterClose":0.105,"fiveDayClose":0.1,"twentyDayClose":0.105,"sixtyDayClose":0.105,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-27","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785110400000,"name":null,"time":"","dateTimestamp":1785074400000,"actualEps":null},{"date":"2026-04-20","symbol":"LDX.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"Post-Mkt","dateTimestamp":1776607200000,"actualEps":null},{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627494658","title":"Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2627494658","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627494658?lang=en_us&edition=fundamental","pubTime":"2026-04-14 13:26","pubTimestamp":1776144405,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  has expanded an agreement with WellStreet Urgent Care to roll out its FebriDx rapid point-of-care test to an additional 43 locations from a single initial site, according to a Tuesday filing with the Australian bourse.The expanded rollout will take place over the next two months, and once it is completed, Lumos expects WellStreet to launch FebriDx at all of the remaining outlets in its network of 163 urgent care locations, per the filing.The increased volume and enhanced payor visibility from the expanded rollout should also strengthen the company's position in future contract negotiations with other health care providers, Lumos said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627460149","title":"Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627460149","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627460149?lang=en_us&edition=fundamental","pubTime":"2026-04-14 09:21","pubTimestamp":1776129696,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  has received a $5 million prepayment for product from US distribution partner PHASE Scientific, confirming that the US Food and Drug Administration's 510 clearance with CLIA waiver for FebriDx product satisfies the milestone requirements of the PHASE distribution agreement, according to a Tuesday Australian bourse filing.The company said the $5 million represents a prepayment for future sales and will be recorded as revenue when the product is shipped, the filing added.The company's shares rose 3% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625604289","title":"Lumos Diagnostics Secures Three-Year Contract to Manufacture Mold Analyzer; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625604289","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625604289?lang=en_us&edition=fundamental","pubTime":"2026-04-08 08:45","pubTimestamp":1775609125,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  secured a three-year contract to manufacture Micro-Pak's Mold Analyzer system, according to a Wednesday filing with the Australian bourse.The company received the first purchase order worth $250,000 under the agreement, the filing said.Lumos developed the mold analyzer system for Micro-Pak.Its shares rose 3% in morning trade on Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625624259","title":"Lumos Diagnostics - First Purchase Order of a$250,000 Under Three-Year Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2625624259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625624259?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:45","pubTimestamp":1775605548,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q12C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625496244","title":"Lumos Diagnostics Holdings Ltd - Secures Contract to Manufacture Micro-Pak Mold Analyzer System","url":"https://stock-news.laohu8.com/highlight/detail?id=2625496244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625496244?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:45","pubTimestamp":1775605548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q12C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624848550","title":"Lumos Diagnostics Holdings Receives Largest Ever Purchase Order of $1.3 Million, Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624848550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624848550?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:27","pubTimestamp":1775006826,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings (ASX:LDX) said it has received its largest-ever purchase order from US exclusive distributor PHASE Scientific, valued at $1.3 million for its FebriDx product, according to a Wednesday Australian bourse filing.The company's shares rose 9% in recent Wednesday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624055557","title":"BRIEF-Lumos Diagnostics Receives Largest Febridx Order To Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2624055557","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624055557?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:21","pubTimestamp":1775006489,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Receives Largest Febridx Order To DateApril 1 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:LUMOS RECEIVES LARGEST FEBRIDX ORDER TO DATEFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40J1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624755454","title":"Lumos Diagnostics Holdings Ltd - Lumos Receives Largest Febridx Order to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2624755454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624755454?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:47","pubTimestamp":1775000873,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624554525","title":"Lumos Diagnostics - Phase Lodges Purchase Order Valued at US$1.3 Mln for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2624554525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624554525?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:47","pubTimestamp":1775000873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1W5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622815950","title":"Lumos Diagnostics to Raise AU$20 Million via Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622815950","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622815950?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:44","pubTimestamp":1774575879,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics (ASX:LDX) received firm commitments to raise AU$20 million through the placement of up to 88.9 million new shares at AU$0.225 apiece, according to a Friday filing with the Australian","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622741813","title":"BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622741813","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622741813?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:27","pubTimestamp":1774574878,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 MillionMarch 27  - Lumos Diagnostics Holdings Ltd LDX.AX:ANNOUNCES SHARE PURCHASE PLAN TO RAISE ABOUT A$2.0 MILLIONOFFER PRICE AT A$0.225 PER SHAREFurther company coverage: LDX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818799","title":"BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818799","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818799?lang=en_us&edition=fundamental","pubTime":"2026-03-27 08:55","pubTimestamp":1774572904,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx** Shares of Australia's Lumos Diagnostics LDX.AX gain as much as 7.6% to A$0.285, their highest point since March 19** The ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL6N40F01X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622721892","title":"Lumos Diagnostics Holdings  - Announces Share Purchase Plan to Raise About a$2.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622721892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622721892?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:09","pubTimestamp":1774566541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622041892","title":"Lumos Diagnostics - Offer Price at a$0.225 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622041892","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622041892?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:09","pubTimestamp":1774566541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622489272","title":"Lumos Diagnostics Holdings Ltd - US FDA Grants Clia Waiver for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2622489272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622489272?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:08","pubTimestamp":1774566494,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019503","title":"BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019503?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390938,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response March 25 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:SEEKS TRADING HALT PENDING UPDATE ON FDA RESPONSE TO FEBRIDX CLIA WAIVER APPLICATIONFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C16H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019545","title":"Lumos Diagnostics Holdings - Seeks Trading Halt Pending Update on FDA Response to Febridx Clia Waiver Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019545?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:21","pubTimestamp":1774390892,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C16H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}